undamentalytics Newsletter

Medicinova vs Rafael Holdings

Rafael Holdings is the larger business, with $874,000 of revenue in fiscal 2026 against $409,657 for Medicinova (2.1 times as much). Rafael Holdings grew faster (-4.7% against -59.0%). Medicinova kept more of each dollar of sales as profit: a net margin of -2928.8% against -3390.7%.

Latest fiscal yearMedicinovaMNOV, 2025Rafael HoldingsRFL, 2026
Revenue $409,657 $874,000
Revenue growth -59.0% -4.7%
Net income −$12.0m −$29.6m
Operating margin -3242.5% —
Net margin -2928.8% -3390.7%
Return on equity -23.1% -36.9%
Free cash flow −$9.8m −$30.0m
Cash $30.8m $22.1m
Total debt $0 $610,000
Debt to equity 0.0% —
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees — —
Market value $70.9m $57.1m
Price vs our value range — —
Moat score — 9 (Weak)
Insider trades, 12 months 0 buys, 1 sales 0 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.